Tactile Medical to Participate in the Oppenheimer Healthcare Conference
March 07 2022 - 7:30AM
Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD),
a medical technology company focused on developing medical devices
for the treatment of patients with underserved chronic diseases at
home, today announced that management will participate in
Oppenheimer’s 32nd Annual Healthcare Conference, which is being
held virtually from March 15th-16th. Management will participate in
a virtual fireside chat on Tuesday, March 15th at 3:20 p.m. Eastern
Time and host virtual 1x1 meetings on Wednesday, March 16th.
A live audio webcast of the fireside chat will
be accessible under the “Events & Webcasts” section of the
Company's investor relations website at
http://investors.tactilemedical.com. An archive of the webcast will
be available for replay following the conference.
About Tactile
Medical
Tactile Medical is a leader in developing and
marketing at-home therapies for people suffering from underserved,
chronic conditions including lymphedema, lipedema, chronic venous
insufficiency and chronic pulmonary disease by helping them live
better and care for themselves at home. The company collaborates
with clinicians to expand clinical evidence, raise awareness,
increase access to care, reduce overall healthcare costs and
improve the quality of life for tens of thousands of patients each
year.
Investor Inquiries:
Mike Piccinino, CFA
Managing Director
ICR Westwicke
investorrelations@tactilemedical.com
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Tactile Systems Technology (NASDAQ:TCMD)
Historical Stock Chart
From Apr 2023 to Apr 2024